VIDEO: Testosterone Alone is Not a Replacement for Lifestyle Changes in Older Men at Risk of Type 2 Diabetes

Published on August 5, 2026

Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes, but an ENDO 2026 study by Gary Wittert, MBBch, MD, finds these benefits require engagement in a lifestyle program.  More than 40 million people in the U.S. and hundreds of millions worldwide have […]

The post VIDEO: Testosterone Alone is Not a Replacement for Lifestyle Changes in Older Men at Risk of Type 2 Diabetes appeared first on Endocrine News.

Continue reading on website
Other news

New Research Greenlights Popular Obesity Medications for High-Risk Cushing’s Syndrome

August 3, 2026
Popular diabetes and weight-loss medications known as GLP-1 receptor agonists do not increase the risk of cancer in patients with endogenous Cushing’s syndrome, according to a comprehensive nationwide study titled, “GLP-1 Recetor Agonist Exposure and Malignancy Risk in Patients with Endogenous Cushing’s Syndrome,” and published in The Journal of Clinical Endocrinology & Metabolism. The findings […

Fall Meetings Offer World-Class Learning for Both Clinicians and Researchers

August 5, 2026
The outstanding ENDO 2026 in Chicago, Ill., is now but a fond memory. Our hardworking member volunteers and staff who organized and executed the meeting can take a well-deserved break. But only a short break. The Society already is busy preparing an exciting lineup of fall meetings that will appeal to both our researcher and […]The post Fall Meetings Offer World-Class Learning for Both Clinicians